Artiva Biotherapeutics, Inc.(ARTV)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ARTV Artiva Biotherapeutics, Inc.

已收盘 11-22 16:00:00 EST

11.20

+0.33

+2.99%

盘后11.20

+0.000.00%

16:01 EST

最高11.98	最低10.79	成交量3.68万
今开11.06	昨收10.88	日振幅10.94%
总市值2.72亿	流通市值4,842万	总股本2,429万
成交额41.55万	换手率0.85%	流通股本432.31万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ARTV","market":"US","secType":"STK","nameCN":"Artiva Biotherapeutics, Inc.","latestPrice":11.2,"timestamp":1732309200000,"preClose":10.875,"halted":0,"volume":36756,"hourTrading":{"tag":"盘后","latestPrice":11.2,"preClose":11.2,"latestTime":"16:01 EST","volume":371,"amount":4155.2,"timestamp":1732309317338},"delay":0,"floatShares":4323072,"shares":24289328,"eps":-11.422745,"marketStatus":"已收盘","marketStatusCode":5,"change":0.325,"latestTime":"11-22 16:00:00 EST","open":11.06,"high":11.98,"low":10.79,"amount":415539.407844,"amplitude":0.109425,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-11.422745,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732525200000},"adr":0,"listingDate":1721361600000,"adjPreClose":10.875,"postHourTrading":{"tag":"盘后","latestPrice":11.2,"preClose":11.2,"latestTime":"16:01 EST","volume":371,"amount":4155.2,"timestamp":1732309317338},"volumeRatio":0.702469},"requestUrl":"/m/hq/s/ARTV","defaultTab":"news","newsList":[{"id":"2485267335","title":"Artiva Biotherapeutics, Inc.盘中异动 早盘股价大涨5.84%报11.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485267335","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485267335?lang=zh_cn&edition=full","pubTime":"2024-11-22 23:17","pubTimestamp":1732288636,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日23时17分，Artiva Biotherapeutics, Inc.股票出现波动，股价大幅上涨5.84%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.72%。其相关个股中，Replimune Group, Inc.、Virpax Pharmaceuticals, Inc.、奥麦罗制药涨幅较大，Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Molecular Templates, Inc.较为活跃，换手率分别为1551.97%、109.07%、81.35%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为55.96%、45.86%、38.10%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc 是一家生物制药公司。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122231716abd7a6a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122231716abd7a6a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARTV"],"gpt_icon":0},{"id":"2485881410","title":"Artiva Biotherapeutics, Inc.盘中异动 股价大涨5.11%报11.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485881410","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485881410?lang=zh_cn&edition=full","pubTime":"2024-11-22 01:12","pubTimestamp":1732209171,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日01时12分，Artiva Biotherapeutics, Inc.股票出现波动，股价急速上涨5.11%。截至发稿，该股报11.52美元/股，成交量9016股，换手率0.04%，振幅4.74%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc 是一家生物制药公司。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122011251a24bbb4c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122011251a24bbb4c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARTV","BK4139"],"gpt_icon":0},{"id":"2484925542","title":"Artiva Biotherapeutics, Inc.盘中异动 早盘急速上涨6.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484925542","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484925542?lang=zh_cn&edition=full","pubTime":"2024-11-19 22:46","pubTimestamp":1732027597,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日22时46分，Artiva Biotherapeutics, Inc.股票出现异动，股价大幅拉升6.94%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.62%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Dermata Therapeutics Inc C/Wts 、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Tff Pharmaceuticals, Inc.、Hcw Biologics Inc.、Exicure, Inc.较为活跃，换手率分别为669.74%、87.32%、73.65%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Klotho Neurosciences Inc C/Wts 21/06/2029 、Tff Pharmaceuticals, Inc.，振幅分别为70.00%、52.14%、45.03%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc 是一家生物制药公司。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111922463898e43843&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111922463898e43843&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARTV","BK4139"],"gpt_icon":0},{"id":"2484913703","title":"Artiva Biotherapeutics, Inc.2024财年第三财季实现净利润-17.47百万美元，同比减少254.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484913703","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484913703?lang=zh_cn&edition=full","pubTime":"2024-11-19 18:00","pubTimestamp":1732010430,"startTime":"0","endTime":"0","summary":"11月19日，Artiva Biotherapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-17.47百万美元，同比减少254.88%；其中营业收入为0.00美元，每股基本收益为-0.72美元。从资产负债表来看，Artiva Biotherapeutics, Inc.总负债24.60百万美元，其中短期债务3.73百万美元，资产负债比为0.10，流动比率为0.12。机构评级：截至2024年11月19日，当前有4家机构对Artiva Biotherapeutics, Inc.目标价做出预测，其中目标均价为21.25美元，其中最低目标价为18.00美元，最高目标价为23.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119180150a24562b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119180150a24562b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARTV"],"gpt_icon":0},{"id":"2484988023","title":"Artiva Biotherapeutics, Inc.盘中异动 下午盘股价大涨5.47%报10.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484988023","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484988023?lang=zh_cn&edition=full","pubTime":"2024-11-19 03:48","pubTimestamp":1731959328,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日03时48分，Artiva Biotherapeutics, Inc.股票出现异动，股价大幅上涨5.47%。截至发稿，该股报10.61美元/股，成交量1.8364万股，换手率0.08%，振幅5.51%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc 是一家生物制药公司。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119034848a243b022&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119034848a243b022&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARTV","BK4139"],"gpt_icon":0},{"id":"2483680209","title":"Artiva Biotherapeutics, Inc.盘中异动 股价大跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483680209","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483680209?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:56","pubTimestamp":1731596206,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时56分，Artiva Biotherapeutics, Inc.股票出现波动，股价急速跳水5.13%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.54%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Elevai Labs, Inc.、Pulmatrix, Inc.涨幅较大，Elevai Labs, Inc.、Pulmatrix, Inc.、Calidi Biotherapeutics, Inc.较为活跃，换手率分别为2009.64%、34.57%、32.04%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Briacell Therapeutics Corp C/Wts 24/02/2025、Pulmatrix, Inc.，振幅分别为75.00%、44.00%、38.76%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc 是一家生物制药公司。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114225646971a693d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114225646971a693d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARTV","BK4139"],"gpt_icon":0},{"id":"2483030858","title":"Artiva Biotherapeutics, Inc.盘中异动 下午盘快速跳水5.01%报12.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483030858","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483030858?lang=zh_cn&edition=full","pubTime":"2024-11-13 02:42","pubTimestamp":1731436975,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日02时42分，Artiva Biotherapeutics, Inc.股票出现波动，股价急速跳水5.01%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.83%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Genprex, Inc.、美第奇新星生物技术涨幅较大，Genprex, Inc.、Cero Therapeutics Holdings, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为543.34%、432.00%、232.77%，振幅较大的相关个股有60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Geovax Labs Inc C/Wts 29/09/2025、Neurosense Therapeutics Ltd C/Wts 10/11/2026 ，振幅分别为209.30%、105.45%、86.87%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc 是一家生物制药公司。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113024255abbac420&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113024255abbac420&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARTV"],"gpt_icon":0},{"id":"2482817634","title":"Artiva Biotherapeutics, Inc.盘中异动 急速下跌5.73%报13.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482817634","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482817634?lang=zh_cn&edition=full","pubTime":"2024-11-09 00:31","pubTimestamp":1731083511,"startTime":"0","endTime":"0","summary":"北京时间2024年11月09日00时31分，Artiva Biotherapeutics, Inc.股票出现波动，股价快速下跌5.73%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Celularity Inc C/Wts 16/07/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Elevai Labs, Inc.、Lipella Pharmaceuticals Inc.、Matinas Biopharma Holdings, Inc.较为活跃，换手率分别为650.61%、62.15%、53.34%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为102.22%、87.00%、52.00%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc 是一家生物制药公司。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109003151abae8575&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109003151abae8575&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARTV"],"gpt_icon":0},{"id":"2481872461","title":"Artiva Biotherapeutics, Inc.盘中异动 早盘快速拉升7.05%报15.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481872461","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481872461?lang=zh_cn&edition=full","pubTime":"2024-11-07 23:44","pubTimestamp":1730994271,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日23时44分，Artiva Biotherapeutics, Inc.股票出现波动，股价急速拉升7.05%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。其相关个股中，Ensysce Biosciences, Inc.、Celularity Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大，Ensysce Biosciences, Inc.、Elevai Labs, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为729.06%、154.97%、94.22%，振幅较大的相关个股有Celularity Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Ensysce Biosciences, Inc.，振幅分别为84.83%、68.89%、57.79%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc 是一家生物制药公司。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107234432abaa9967&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107234432abaa9967&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARTV"],"gpt_icon":0},{"id":"2481981613","title":"Artiva Biotherapeutics, Inc.盘中异动 快速拉升5.04%报12.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481981613","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481981613?lang=zh_cn&edition=full","pubTime":"2024-11-06 23:08","pubTimestamp":1730905725,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日23时08分，Artiva Biotherapeutics, Inc.股票出现异动，股价急速上涨5.04%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.42%。其相关个股中，Sonnet Biotherapeutics Holdings, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大，Sonnet Biotherapeutics Holdings, Inc.、Elevai Labs, Inc.、Zyversa Therapeutics, Inc.较为活跃，换手率分别为1587.89%、179.08%、81.04%，振幅较大的相关个股有Sonnet Biotherapeutics Holdings, Inc.、Protagenic Therapeutics, Inc.、Neuraxis, Inc.，振幅分别为73.16%、24.63%、23.51%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc 是一家生物制药公司。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106230845971a4d0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106230845971a4d0a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARTV","BK4139"],"gpt_icon":0},{"id":"2481553946","title":"Artiva Biotherapeutics, Inc.盘中异动 股价大涨5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481553946","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481553946?lang=zh_cn&edition=full","pubTime":"2024-11-05 03:21","pubTimestamp":1730748076,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日03时21分，Artiva Biotherapeutics, Inc.股票出现异动，股价快速拉升5.41%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.46%。其相关个股中，Neurogene Inc.、Tenaya Therapeutics, Inc.、Disc Medicine, Inc.涨幅较大，Elevai Labs, Inc.、Nls Pharmaceutics Ltd.、Gri Bio, Inc.较为活跃，换手率分别为450.53%、284.37%、100.31%，振幅较大的相关个股有Sab Biotherapeutics Inc C/Wts 22/10/2026 、Ocean Biomedical Inc C/Wts 14/02/2028 、In8Bio, Inc.，振幅分别为52.25%、45.56%、45.39%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc 是一家生物制药公司。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105032116a215c0d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105032116a215c0d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARTV","BK4139"],"gpt_icon":0},{"id":"2480078854","title":"Artiva Biotherapeutics, Inc.盘中异动 临近收盘快速拉升5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480078854","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480078854?lang=zh_cn&edition=full","pubTime":"2024-11-02 04:00","pubTimestamp":1730491246,"startTime":"0","endTime":"0","summary":"北京时间2024年11月02日04时00分，Artiva Biotherapeutics, Inc.股票出现异动，股价急速拉升5.42%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.50%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Revolution Medicines Inc C/Wts 17/12/2026 、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大，Theriva Biologics, Inc.、Ensysce Biosciences, Inc.、Gri Bio, Inc.较为活跃，换手率分别为3740.76%、955.40%、905.74%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Tc Biopharm  Plc C/Wts 10/02/2028 、Immatics N V C/Wts 01/07/2025 ，振幅分别为122.67%、101.75%、62.87%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc 是一家生物制药公司。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241102040046971a3ef0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241102040046971a3ef0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARTV","BK4139"],"gpt_icon":0},{"id":"2479759081","title":"Artiva Biotherapeutics, Inc.盘中异动 股价大跌5.25%报10.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479759081","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479759081?lang=zh_cn&edition=full","pubTime":"2024-10-31 03:20","pubTimestamp":1730316048,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日03时20分，Artiva Biotherapeutics, Inc.股票出现波动，股价大幅下跌5.25%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.31%。其相关个股中，Tharimmune, Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Ensysce Biosciences, Inc.涨幅较大，Tharimmune, Inc.、Ensysce Biosciences, Inc.、Gri Bio, Inc.较为活跃，换手率分别为5214.32%、3108.16%、432.49%，振幅较大的相关个股有Tharimmune, Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Ensysce Biosciences, Inc.，振幅分别为146.80%、91.64%、77.90%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc 是一家生物制药公司。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031032048ab85d68b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031032048ab85d68b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARTV","BK4139"],"gpt_icon":0},{"id":"2478482724","title":"Artiva Biotherapeutics, Inc.盘中异动 急速上涨5.16%报11.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478482724","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478482724?lang=zh_cn&edition=full","pubTime":"2024-10-28 22:43","pubTimestamp":1730126595,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日22时43分，Artiva Biotherapeutics, Inc.股票出现波动，股价快速上涨5.16%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.60%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Monte Rosa Therapeutics, Inc.、Eyepoint Pharmaceuticals, Inc.涨幅较大，Tc Biopharm  Plc、Genprex, Inc.、Viracta Therapeutics, Inc.较为活跃，换手率分别为640.02%、56.59%、53.23%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Klotho Neurosciences Inc C/Wts 21/06/2029 、Monte Rosa Therapeutics, Inc.，振幅分别为87.13%、84.14%、46.83%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc 是一家生物制药公司。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028224316a1f2743b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028224316a1f2743b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARTV","BK4139"],"gpt_icon":0},{"id":"2478338189","title":"Artiva Biotherapeutics, Inc.盘中异动 股价大涨5.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478338189","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478338189?lang=zh_cn&edition=full","pubTime":"2024-10-25 21:31","pubTimestamp":1729863069,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日21时31分，Artiva Biotherapeutics, Inc.股票出现波动，股价急速拉升5.81%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。其相关个股中，Elevai Labs, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、180 Life Sciences Corp.涨幅较大，180 Life Sciences Corp.、Elevai Labs, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为445.82%、279.08%、22.77%，振幅较大的相关个股有Tevogen Bio Holdings Inc C/Wts 14/02/2029 、180 Life Sciences Corp.、Elevai Labs, Inc.，振幅分别为66.85%、20.36%、18.76%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc 是一家生物制药公司。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025213109a1ea7ff6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025213109a1ea7ff6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARTV","BK4139"],"gpt_icon":0},{"id":"2477563747","title":"Artiva Biotherapeutics, Inc.盘中异动 快速下挫7.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477563747","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477563747?lang=zh_cn&edition=full","pubTime":"2024-10-24 03:14","pubTimestamp":1729710889,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日03时14分，Artiva Biotherapeutics, Inc.股票出现波动，股价大幅下跌7.17%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.27%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Virax Biolabs Group Limited涨幅较大，Virax Biolabs Group Limited、Cns Pharmaceuticals, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为1921.84%、1649.67%、520.46%，振幅较大的相关个股有Cns Pharmaceuticals, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为129.93%、109.26%、95.84%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc 是一家生物制药公司。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024031449971a1df7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024031449971a1df7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARTV","BK4139"],"gpt_icon":0},{"id":"2477297356","title":"Artiva Biotherapeutics, Inc.盘中异动 早盘大幅拉升5.44%报11.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477297356","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477297356?lang=zh_cn&edition=full","pubTime":"2024-10-22 23:00","pubTimestamp":1729609203,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日23时00分，Artiva Biotherapeutics, Inc.股票出现异动，股价急速上涨5.44%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.84%。其相关个股中，Ensysce Biosciences, Inc.、Genprex, Inc.、Sangamo Therapeutics, Inc.涨幅较大，Genprex, Inc.、Ensysce Biosciences, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为4440.72%、3933.23%、1949.11%，振幅较大的相关个股有Ensysce Biosciences, Inc.、Aptevo Therapeutics Inc.、Genprex, Inc.，振幅分别为170.68%、99.41%、81.46%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc 是一家生物制药公司。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022230004971a1a1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022230004971a1a1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARTV","BK4139"],"gpt_icon":0},{"id":"2477647218","title":"Artiva Biotherapeutics, Inc.盘中异动 早盘股价大跌5.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477647218","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477647218?lang=zh_cn&edition=full","pubTime":"2024-10-21 22:53","pubTimestamp":1729522393,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日22时53分，Artiva Biotherapeutics, Inc.股票出现异动，股价急速下跌5.96%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.73%。其相关个股中，Genprex, Inc.、Gri Bio, Inc.、Biovie Inc.涨幅较大，Genprex, Inc.、Gri Bio, Inc.、Biovie Inc.较为活跃，换手率分别为5084.46%、2796.36%、1161.20%，振幅较大的相关个股有Genprex, Inc.、Biovie Inc.、Aptevo Therapeutics Inc.，振幅分别为292.25%、157.02%、118.79%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc 是一家生物制药公司。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102122531398e3d8fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102122531398e3d8fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARTV","BK4139"],"gpt_icon":0},{"id":"2476242481","title":"Artiva Biotherapeutics, Inc.盘中异动 大幅跳水5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476242481","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476242481?lang=zh_cn&edition=full","pubTime":"2024-10-18 02:21","pubTimestamp":1729189265,"startTime":"0","endTime":"0","summary":"北京时间2024年10月18日02时21分，Artiva Biotherapeutics, Inc.股票出现异动，股价急速下挫5.07%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.13%。其相关个股中，Molecular Templates, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Engene Holdings Inc C/Wts 31/10/2028  Cl A涨幅较大，Molecular Templates, Inc.、Notable Labs, Ltd.、180 Life Sciences Corp.较为活跃，换手率分别为2610.45%、937.91%、280.01%，振幅较大的相关个股有Molecular Templates, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为259.74%、147.48%、104.84%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc 是一家生物制药公司。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101802210598e3d0f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101802210598e3d0f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARTV"],"gpt_icon":0},{"id":"2475891647","title":"Artiva Biotherapeutics, Inc.盘中异动 股价大跌5.09%报11.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475891647","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475891647?lang=zh_cn&edition=full","pubTime":"2024-10-16 22:31","pubTimestamp":1729089079,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日22时31分，Artiva Biotherapeutics, Inc.股票出现异动，股价急速下跌5.09%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.88%。其相关个股中，180 Life Sciences Corp.、180 Life Sciences Corp C/Wts 07/11/2025、Korro Bio, Inc.涨幅较大，180 Life Sciences Corp.、Biodexa Pharmaceuticals Plc、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为5329.30%、974.27%、360.41%，振幅较大的相关个股有180 Life Sciences Corp.、180 Life Sciences Corp C/Wts 07/11/2025、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为623.68%、279.52%、121.40%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc 是一家生物制药公司。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101622311998e3ccc8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101622311998e3ccc8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARTV"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.artivabio.com","stockEarnings":[{"period":"1week","weight":0.0347},{"period":"1month","weight":-0.0376},{"period":"3month","weight":0.0875},{"period":"6month","weight":-0.0938},{"period":"ytd","weight":-0.0938}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Artiva Biotherapeutics, Inc.于2019年2月14日在特拉华州注册成立。该公司是一家临床阶段的生物技术公司，专注于为患有破坏性自身免疫性疾病和癌症的患者开发基于自然杀伤（NK）细胞的疗法。","exchange":"NASDAQ","name":"Artiva Biotherapeutics, Inc.","nameEN":"Artiva Biotherapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Artiva Biotherapeutics, Inc.(ARTV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Artiva Biotherapeutics, Inc.(ARTV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Artiva Biotherapeutics, Inc.,ARTV,Artiva Biotherapeutics, Inc.股票,Artiva Biotherapeutics, Inc.股票老虎,Artiva Biotherapeutics, Inc.股票老虎国际,Artiva Biotherapeutics, Inc.行情,Artiva Biotherapeutics, Inc.股票行情,Artiva Biotherapeutics, Inc.股价,Artiva Biotherapeutics, Inc.股市,Artiva Biotherapeutics, Inc.股票价格,Artiva Biotherapeutics, Inc.股票交易,Artiva Biotherapeutics, Inc.股票购买,Artiva Biotherapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Artiva Biotherapeutics, Inc.(ARTV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Artiva Biotherapeutics, Inc.(ARTV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}